A firm founded in 2014 and based in Silicon Valley invests in several fields including digital health, healthcare IT, and medical devices. The firm is currently raising its second fund, and typically invests an average of $300,000 per company, though this is dependent on the technology as the investment size may increase, particularly for hardware-based technology. The firm typically co-invests at present but is anticipating leading investments with the new fund. The firm typically makes 12-20 new investments per year, and focuses on companies based in North America (USA & Canada), though is open to looking at companies based on a global-level. Furthermore, the firm has a considerable value-add in supporting companies that may be interested in moving their markets to Asia by passing potential deals to the firm’s Shanghai office as its source of deal flow, and making the right introductions to Asian investors and/or distribution partners.
The firm is open to all subsectors of digital health, healthcare IT, diagnostics, mobile app healthcare technologies, and all classes of medical devices. The firm is indication agnostic and looks primarily at early-stage companies, particularly at the seed pre-Series A stage.
The firm does not have a particular management team requirement. The firm will help the company fill the team if necessary. If leading the round, the firm will take a board seat after an investment.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment